SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-377211
Filing Date
2013-09-25
Accepted
2013-09-25 08:32:02
Documents
8
Period of Report
2013-09-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d603170d8k.htm 8-K 41524
2 EX-4.1 d603170dex41.htm EX-4.1 80887
3 EX-4.2 d603170dex42.htm EX-4.2 120248
4 EX-10.1 d603170dex101.htm EX-10.1 249031
5 EX-10.2 d603170dex102.htm EX-10.2 30949
6 EX-10.3 d603170dex103.htm EX-10.3 26445
7 EX-10.4 d603170dex104.htm EX-10.4 16167
8 EX-10.5 d603170dex105.htm EX-10.5 52741
  Complete submission text file 0001193125-13-377211.txt   619619
Mailing Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122
Business Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122 858-452-6600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 131113440
SIC: 2836 Biological Products, (No Diagnostic Substances)